| Literature DB >> 25166927 |
McKenzie Andre, Chris G Wolff, Rudolf H Tangermann, Paul Chenoweth, Graham Tallis, Jean Baptiste Kamgang, Steven G F Wassilak.
Abstract
Since 1988, when the Global Polio Eradication Initiative (GPEI) began, the annual number of polio cases has decreased by >99%. Only three countries remain that have never interrupted wild poliovirus (WPV) transmission: Afghanistan, Nigeria, and Pakistan. Since 2001, outbreaks have occurred in 31 formerly polio-free counties in Africa, with outbreaks in 25 countries caused by WPV originating in Nigeria (2-4). After the declaration of the World Health Assembly of polio eradication as a programmatic emergency in 2012, efforts to identify areas at high risk for importation-associated outbreaks and to reduce that risk have been intensified. This report updates the 2013 assessment of the risk for outbreaks attributable to importation of poliovirus in 33 countries in Africa, using indicators of childhood susceptibility to poliovirus and proximity to countries currently affected by polio . From January 2013 to August 12, 2014, outbreaks occurred in five African countries. Four of the five (Cameroon, Equatorial Guinea, Ethiopia, and Somalia) have had recent transmission (cases within the previous 12 months). Based on the current risk assessment, 15 countries are considered to be at high risk for WPV outbreaks, five at moderate-to-high risk, seven at moderate risk, and six at low risk. In 15 of the 33 countries, less than half of the population resides in areas where surveillance performance indicators have met minimum targets. Enhanced, coordinated activities to raise childhood immunity are underway in 2014 to prevent additional WPV spread. Although substantial progress toward polio eradication has occurred in Nigeria, all African countries remain at risk for outbreaks as long as WPV continues to circulate anywhere on the continent.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25166927 PMCID: PMC5779440
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Key risk indicators for 25 countries with wild poliovirus (WPV) cases during 2009–2014 and eight selected neighboring countries, by risk for transmission after an importation of WPV — Africa, 2014
| Childhood immunity indicators | Routine immunization indicators | Surveillance quality indicators | Other factors | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||||||
| Risk level/Country | Risk tier: routine immunization with OPV3 national coverage | Risk tier: vaccine history ≥3 doses in children with NPAFP | Risk tier: vaccine history zero doses in children with NPAFP | OPV3 national coverage (%) | % districts with ≥80% OPV3 coverage | Risk tier for % provinces with ≥2 AFP cases per 100,000 children aged <15 yrs | Risk tier for % of provinces with 80% of AFP stool specimen collection within 2 wks | % of population residing in a province that meets both criteria | Areas of insecurity in the country that disrupt vaccine delivery | No. of WPV importations 2009–2013 | Outbreak response countries (OR) and other priority countries (PC) | Borders with a country with WPV case in the last 12 months |
|
| ||||||||||||
| Benin | High | High | High | 69 | 84 | Mod | Low | 59 | No | 0 | PC | Yes |
| Cameroon | Mod | High | High | 89 | 78 | Low | High | 36 | Yes | 3 | OR | Yes |
| CAR | High | Low | Low | 23 | 4 | High | Low | 35 | Yes | 2 | PC | Yes |
| Chad | High | Mod | Low | 48 | 60 | Low | Mod | 73 | Yes | 4 | PC | Yes |
| Congo | High | High | High | 69 | 73 | Low | Mod | 79 | No | 1 | PC | Yes |
| Djibouti | Mod | High | Low | 82 | 50 | Low | Low | 100 | No | 0 | Yes | |
| Equatorial Guinea | High | High | Low | 3 | 6 | High | High | 0 | No | 0 | OR | Yes |
| Ethiopia | High | High | Mod | 72 | 50 | Low | High | 21 | No | 1 | OR | Yes |
| Gabon | High | Low | Low | 79 | 33 | Low | High | 0 | No | 1 | PC | Yes |
| Guinea | High | High | Low | 63 | 92 | Low | Mod | 38 | No | 2 | No | |
| Kenya | High | Low | Low | 76 | 45 | Low | Low | 91 | No | 3 | Yes | |
| Niger | High | Low | Low | 70 | 90 | High | High | 0 | Yes | 11 | PC | Yes |
| Somalia | High | High | High | 42 | 6 | Low | Low | 99 | Yes | 1 | OR | Yes |
| South Sudan | High | Low | Low | 45 | 23 | High | Low | 19 | Yes | 0 | Yes | |
| Uganda | High | High | Mod | 78 | 83 | Mod | Mod | 46 | No | 0 | No | |
|
| ||||||||||||
| Angola | Low | High | Low | 93 | 66 | Mod | Low | 46 | No | 1 | PC | No |
| Cote d’Ivoire | Mod | High | Low | 88 | 99 | Low | Mod | 16 | No | 2 | PC | No |
| DRC | High | Mod | Low | 72 | 80 | Low | Low | 90 | Yes | 3 | PC | No |
| Liberia | Mod | High | Low | 89 | 87 | Mod | Low | 23 | No | 2 | No | |
| Mali | High | Low | Low | 74 | 77 | Low | Low | 96 | Yes | 6 | PC | No |
|
| ||||||||||||
| Burkina Faso | Mod | Low | Low | 88 | 100 | Low | Low | 95 | No | 1 | No | |
| Eritrea | Low | Low | Low | 94 | 40 | Mod | Low | 65 | No | 1 | Yes | |
| Guinea-Bissau | Mod | Low | Low | 80 | 91 | Low | High | 0 | No | 0 | No | |
| Mauritania | Mod | Low | Low | 80 | 42 | Low | Mod | 61 | No | 1 | No | |
| Senegal | Low | Mod | Mod | 92 | 32 | Mod | Mod | 54 | No | 3 | No | |
| Sudan | Low | Low | Low | 93 | 93 | Low | Low | 100 | Yes | 0 | Yes | |
| Togo | Mod | Low | Low | 84 | 95 | Low | Low | 58 | No | 2 | No | |
|
| ||||||||||||
| Burundi | Low | Low | Low | 96 | 93 | High | Low | 38 | No | 1 | No | |
| Gambia | Low | Low | Low | 97 | 100 | Low | Mod | 67 | No | 0 | No | |
| Ghana | Low | Low | Low | 90 | 75 | High | Low | 34 | No | 0 | No | |
| Rwanda | Low | Low | Low | 98 | 100 | Low | Low | 100 | No | 0 | No | |
| Sierra Leone | Low | Low | Low | 92 | 93 | Mod | Low | 79 | No | 1 | No | |
| Tanzania | Low | Low | Low | 91 | 79 | Mod | Low | 66 | No | 0 | No | |
Abbreviations: OPV3 = third dose of oral poliovirus vaccine; NPAFP = nonpolio acute flaccid paralysis; AFP = acute flaccid paralysis; CAR = Central African Republic; DRC = Democratic Republic of the Congo.
Countries were considered to be at low risk at ≥90%, moderate risk at 80%–89%, and high risk at <80%.
OPV3 coverage is based on World Health Organization (WHO)/United Nations Children’s Fund (UNICEF) estimates of the national vaccination coverage of the third dose of diphtheria-tetanus-pertussis (DTP3) for 2013.
Nonpolio acute flaccid paralysis database maintained by WHO.
Countries were considered to be at low risk at <5%, moderate risk at 5%–10%, and high risk at >10%.
Routine immunization administrative data as reported via WHO-UNICEF Joint Reporting Form, 2013, are based on use of DTP3 as proxy for OPV3 that does not count OPV doses administered during supplementary immunization activities.
Countries were considered to be at low risk at ≥80%, moderate risk at 50%–79%, and high risk at <50%.
Areas with limitations in access and/or threats to the physical security of vaccination staff members.
Nigeria, Cameroon, Ethiopia, Somalia, and Equatorial Guinea.
FIGUREOral poliovirus vaccine dose history among children aged 6–59 months with nonpolio acute flaccid paralysis in countries experiencing importations of wild poliovirus during 2009–2013 and selected neighboring countries — Africa, July 2013–June 2014
Risk mitigation activities for 25 countries with wild poliovirus (WPV) cases during 2009–2014 and eight selected neighboring countries, by risk for transmission after an importation of WPV — Africa, 2012–2014
| Supplementary immunization activities: National and subnational immunization days (NID/SNID) | Surveillance strengthening activities: national program assessments (PA), | |||||
|---|---|---|---|---|---|---|
|
|
| |||||
| Risk level/Country | Jan 2012–Dec 2012 (NID/SNID) | Jan 2013–Dec 2013 (NID/SNID) | Jan 2014–Jun 2014 (NID/SNID) | Jul 2014–Dec 2014 (NID/SNID) (Planned) | Jan 2013–Jun 2014 | Jul 2014–Dec 2014 (Planned) |
|
| ||||||
| Benin | 3/0 | 4/0 | 2/0 | 1/0 | SR | |
| Cameroon | 0/4 | 2/4 | 6/0 | 3/2 | PA, ST | PA, ST |
| CAR | 5/2 | 0/4 | 1/1 | 2/2 | PA | |
| Chad | 3/10 | 4/8 | 2/1 | 1/3 | SR, ST | PA |
| Congo | 0/0 | 2/0 | 1/0 | 3/0 | ||
| Djibouti | 1/0 | 3/0 | 0/1 | 2/0 | ||
| Equatorial Guinea | 0/0 | 0/0 | 3/1 | 4/0 | ST | |
| Ethiopia | 0/3 | 2/8 | 0/4 | 2/2 | PA, ST | PA, ST |
| Gabon | 0/0 | 0/0 | 1/0 | 3/0 | ST | |
| Guinea | 4/1 | 3/0 | 0/0 | 2/0 | SR | |
| Kenya | 0/6 | 1/8 | 3/3 | 0/2 | PA, SR, ST | PA, SR, ST |
| Niger | 4/4 | 5/3 | 2/1 | 2/1 | SR, PA | ST |
| Somalia | 0/4 | 7/17 | 3/9 | 3/4 | PA, ST | PA, ST |
| South Sudan | 4/1 | 4/2 | 2/0 | 2/0 | ST | |
| Uganda | 0/2 | 0/2 | 0/1 | 1/1 | PA, SR | |
|
|
|
|
|
| ||
|
| ||||||
| Angola | 3/1 | 3/0 | 0/0 | 1/1 | ||
| Cote d’Ivoire | 4/0 | 3/0 | 1/0 | 2/0 | SR | |
| DRC | 2/8 | 2/3 | 0/3 | 1/2 | SR, ST | SR |
| Liberia | 3/1 | 3/0 | 0/0 | 2/0 | PA | |
| Mali | 1/6 | 4/2 | 2/0 | 1/1 | SR | |
|
|
|
|
|
| ||
|
| ||||||
| Burkina Faso | 4/1 | 4/1 | 2/0 | 2/0 | SR | |
| Eritrea | 0/0 | 2/0 | 0/0 | 0/0 | ST | |
| Guinea-Bissau | 1/0 | 2/0 | 0/0 | 2/0 | SR | |
| Mauritania | 3/0 | 2/0 | 0/0 | 2/0 | SR | |
| Senegal | 1/0 | 2/0 | 0/0 | 2/0 | SR | |
| Sudan | 3/1 | 2/2 | 1/1 | 1/0 | ||
| Togo | 1/0 | 2/0 | 0/0 | 2/0 | ||
|
|
|
|
|
| ||
|
| ||||||
| Burundi | 0/0 | 0/0 | 0/0 | 0/0 | ||
| Gambia | 1/0 | 2/0 | 0/0 | 2/0 | ||
| Ghana | 1/0 | 2/0 | 0/0 | 2/0 | SR | |
| Rwanda | 0/2 | 0/0 | 0/0 | 0/0 | ||
| Sierra Leone | 2/1 | 4/0 | 0/0 | 2/0 | ||
| Tanzania | 0/0 | 0/0 | 0/0 | 0/0 | ||
|
|
|
|
|
| ||
Abbreviations: CAR = Central African Republic; DRC = Democratic Republic of the Congo.
Program assessments include assessments conducted after the occurrence of a case of WPV infection or circulating vaccine-derived poliovirus infection and planned comprehensive immunization program reviews.
Countries were considered to be at high risk for outbreaks in 2014 if two immunity indicators fell into a high-risk tier. Countries were considered to be at moderate-to-high risk for outbreaks if one of three immunity indicators fell into a high-risk tier. Countries were considered to be at moderate risk for outbreaks if any of the population immunity risk criteria suggested moderate vulnerability. A risk category for a country was increased one level if it shared a border with any country with recent transmission in the last 12 months.